ECSP23088732A - Moduladores de trex1 - Google Patents

Moduladores de trex1

Info

Publication number
ECSP23088732A
ECSP23088732A ECSENADI202388732A ECDI202388732A ECSP23088732A EC SP23088732 A ECSP23088732 A EC SP23088732A EC SENADI202388732 A ECSENADI202388732 A EC SENADI202388732A EC DI202388732 A ECDI202388732 A EC DI202388732A EC SP23088732 A ECSP23088732 A EC SP23088732A
Authority
EC
Ecuador
Prior art keywords
trex1
modulators
compositions
compounds
variety
Prior art date
Application number
ECSENADI202388732A
Other languages
English (en)
Inventor
Aaron Coffin
Jonathan Wilson
Avinash Khanna
Julian Levell
Jennifer Rocnik
Mary-Margaret Zablocki
David Guerin
William Mcelroy
Original Assignee
Constellation Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Constellation Pharmaceuticals Inc filed Critical Constellation Pharmaceuticals Inc
Publication of ECSP23088732A publication Critical patent/ECSP23088732A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Compuestos de Fórmula (I): y sales farmacéuticamente aceptables y composiciones de los mismos, que son útiles para el tratamiento de una variedad de condiciones asociadas con la TREX1.
ECSENADI202388732A 2021-04-26 2023-11-23 Moduladores de trex1 ECSP23088732A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163179723P 2021-04-26 2021-04-26

Publications (1)

Publication Number Publication Date
ECSP23088732A true ECSP23088732A (es) 2024-02-29

Family

ID=81598085

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202388732A ECSP23088732A (es) 2021-04-26 2023-11-23 Moduladores de trex1

Country Status (14)

Country Link
EP (1) EP4330254A1 (es)
JP (1) JP2024517715A (es)
KR (1) KR20240028979A (es)
CN (1) CN117545754A (es)
AR (1) AR125448A1 (es)
AU (1) AU2022264711A1 (es)
BR (1) BR112023022298A2 (es)
CA (1) CA3216752A1 (es)
CO (1) CO2023015732A2 (es)
DO (1) DOP2023000236A (es)
EC (1) ECSP23088732A (es)
IL (1) IL308016A (es)
TW (1) TW202309019A (es)
WO (1) WO2022232004A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024061300A1 (en) * 2022-09-22 2024-03-28 Insilico Medicine Ip Limited Inhibitors of trex1 and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012151567A1 (en) * 2011-05-05 2012-11-08 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for preventing and treating influenza
PL3891145T3 (pl) * 2018-12-06 2023-08-07 Constellation Pharmaceuticals, Inc. Modulatory trex1

Also Published As

Publication number Publication date
CA3216752A1 (en) 2022-11-03
IL308016A (en) 2023-12-01
WO2022232004A1 (en) 2022-11-03
AR125448A1 (es) 2023-07-19
CO2023015732A2 (es) 2024-02-05
BR112023022298A2 (pt) 2023-12-26
JP2024517715A (ja) 2024-04-23
AU2022264711A1 (en) 2023-11-09
EP4330254A1 (en) 2024-03-06
KR20240028979A (ko) 2024-03-05
CN117545754A (zh) 2024-02-09
TW202309019A (zh) 2023-03-01
DOP2023000236A (es) 2024-02-29

Similar Documents

Publication Publication Date Title
CL2021001461A1 (es) Moduladores de trex1
CL2023003041A1 (es) Derivados de triazina que tienen actividad inhibidora de la replicación del virus y composición farmacéutica
CL2020002698A1 (es) Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos
CO2020012824A2 (es) Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma
DOP2016000017A (es) Nuevos compuestos tricíclicos
CO2018000589A2 (es) Oxiesteroles y composiciones farmacéuticas que los contienen
CO2017009891A2 (es) Inhibidores de inhibidores del factor beta de crecimiento de transformación (tgf-beta)
UY35617A (es) Inhibidores de la fosfatidilinositol 3-quinasa
CU20210035A7 (es) Compuestos de azalactam como inhibidores de hpk 1
DOP2019000140A (es) Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih
CO2020013840A2 (es) Benzofurano, benzopirrol, benzotiofeno sustituidos y otros inhibidores del complemento estructuralmente relacionados
CO2020014677A2 (es) Compuestos tetrahidro-1h-pirazino[2,1-a]isoindolilquinolina para el tratamiento de enfermedades autoinmunes
ECSP089019A (es) Inhibidores de sulfonamida tricíclicos, fusionados del gama secretasa
ECSP23088732A (es) Moduladores de trex1
ECSP22085221A (es) Pirrolopirimidinaminas como inhibidores del sistema del complemento
CL2022001529A1 (es) Nuevos derivados de metilquinazolinona
CL2022001173A1 (es) Forma cristalina de la base libre de un receptor del componente c5a del complemento
CL2020003380A1 (es) Compuestos que aumentan la actividad del proteosoma.
CL2022001183A1 (es) Formas de sal de un receptor del componente c5a del complemento
CU20220025A7 (es) Inihibidores del factor d del complemento para administración oral
CL2022000802A1 (es) Compuestos heterocíclicos de arilmetileno como bloqueadores del canal shaker de potasio kv1.3
CO2021004873A2 (es) Inhibidores de o-glicoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa
CO2023016367A2 (es) Moduladores de trex1
CO2021017202A2 (es) Compuestos tricíclicos
ECSP23075535A (es) Compuestos cíclicos y métodos de uso